All items in the Healthy Skepticism Library
All the 20545 items in the Healthy Skepticism Library are listed below in order of publication date with the most recent at the top. There are 100 items per page.
Page 155 of 206 pages ‹ First < 153 154 155 156 157 > Last ›
HSL10432
New drugs: watch out for unexpected adverse effects.
Prescrire Int. 2002 Oct;11:(61):150-1
http://www.ncbi.nlm.nih.gov/pubmed/12378747
HSL2449
Transparency International.
Slovak judge, German pharmacologist and Brazilian campaigner win anti-corruption award
2002 Sep 30;
http://www.transparency.org/pressreleases_archive/2002/2002.09.30.anti_corruption_award.html
HSL2082
Bull SA, Hu XH, Hunkeler EM, Lee JY, Ming EE, Markson LE, Fireman B.
Discontinuation of use and switching of antidepressants: influence of patient-physician communication.
JAMA 2002 Sep 18;288:(11):1403-9
http://jama.ama-assn.org/cgi/content/full/288/11/1403
HSL19523
Petersen M.
Pediatric book on breast-feeding stirs controversy
The New York Times 2002 Sep 18
http://www.nytimes.com/2002/09/18/business/media/18ADCO.html
HSL1690
Shear NH.
Principles of influence.
CMAJ 2002 Sep 17;167:(6):628
http://www.cmaj.ca/cgi/content/full/167/6/628
HSL17378
Marbin Miller C
Mind-altering drugs given to some babies in DCF's care
Miami Herald 2002 Sep 17
HSL1993
Adams C.
Firms Pressure FDA to Relax Rules on Commercial Speech
The Wall Street Journal 2002 Sep 17
http://online.wsj.com/article/SB1032211864319468275.html?mod=googlewsj
HSL1808
Salleh A.
Prescription drug ads under attack
ABC Science Online 2002 Sep 16
http://www.abc.net.au/science/articles/2002/09/16/675698.htm
HSL1975
Newby DA, Henry DA.
Drug advertising: truths, half-truths and few statistics.
Med J Aust 2002 Sep 16;177:(6):285-6
http://www.mja.com.au/public/issues/177_06_160902/new10443_fm.html
HSL2243
Loke TW, Koh FC, Ward JE.
Pharmaceutical advertisement claims in Australian medical publications.
Med J Aust 2002 Sep 16;177:(6):291-3
http://www.mja.com.au/public/issues/177_06_160902/lok10004_fm.html
HSL1979
Moynihan R.
Alosetron: a case study in regulatory capture, or a victory for patients' rights?
BMJ 2002 Sep 14;325:(7364):592-5
http://bmj.bmjjournals.com/cgi/content/full/325/7364/592
HSL17899
Lièvre M
Alosetron for irritable bowel syndrome
BMJ 2002 Sep 14;325:(7364):555–556
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1124090/
HSL17900
Jackson T
Press: Both sides now
BMJ 2002 Sep 14;325:(7364):603
http://www.bmj.com/cgi/content/full/325/7364/603/a
HSL1809
Burson-Marsteller's Task Force
Media Watch. Australian Broadcasting Commission 2002 Sep 13
www.abc.net.au/mediawatch/transcripts/300902_s3.htm
HSL5423
Accreditation Council for Graduate Medical Education
Principles to Guide the Relationship between Graduate Medical Education and Industry
: Accreditation Council for Graduate Medical Education 2002 Sep 10
http://www.acgme.org/acWebsite/positionPapers/pp_GMEGuide.pdf
HSL2004
Wysong P.
Time with drug reps affects prescribing: study
The Medical Post. 2002 Sep 8
HSL2482
Clifford TJ, Barrowman NJ, Moher D.
Funding source, trial outcome and reporting quality: are they related? Results of a pilot study
BMC Health Serv Res 2002 September 4;2:(1):18
http://www.biomedcentral.com/1472-6963/2/18
HSL7674
McAllister JC 3rd.
Providing for the pharmaceutically indigent.
Am J Health Syst Pharm 2002 Sep 1;59:(17):1678-9
http://www.ajhp.org/cgi/reprint/59/17/1678
HSL8945
Cox TP.
Forging Alliances: Advocacy Partners
Pharmaceutical Executive 2002 Sep 1
http://www.pharmexec.com/pharmexec/article/articleDetail.jsp?id=29974
HSL1259
Wazana A, Primeau F.
Ethical considerations in the relationship between physicians and the pharmaceutical industry.
Psychiatr Clin North Am 2002 Sep;25:(3):647-63,
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=12232977
HSL1611
Sagarin BJ, Cialdini RB, Rice WE, Serna SB.
Dispelling the illusion of invulnerability: the motivations and mechanisms of resistance to persuasion.
J Pers Soc Psychol 2002 Sep;83:(3):526-41
http://content.apa.org/journals/psp/83/3/526
HSL1917
Wall LL, Brown D.
Pharmaceutical sales representatives and the doctor/patient relationship.
Obstet Gynecol 2002 Sep;100:(3):594-9
http://www.greenjournal.org/cgi/content/full/100/3/594
HSL1932
Stewart KA, Neumann PJ.
FDA actions against misleading or unsubstantiated economic and quality-of-life promotional claims: an analysis of warning letters and notices of violation.
Value Health 2002 Sep-Oct;5:(5):389-96
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=12201856
HSL1961
Safer DJ.
Design and reporting modifications in industry-sponsored comparative psychopharmacology trials.
J Nerv Ment Dis 2002 Sep;190:(9):583-92
http://meta.wkhealth.com/pt/pt-core/template-journal/lwwgateway/media/landingpage.htm?issn=0022-3018&volume=190&issue=9&spage=583
HSL1976
Neumann PJ, Zivin Bambauer K, Ramakrishnan V, Stewart KA, Bell CM.
Economic messages in prescription drug advertisements in medical journals.
Med Care 2002 Sep;40:(9):840-5
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=12218774
HSL1981
Motola G, Mazzeo F, Rinaldi B, Capuano A, Rossi S, Russo F, Vitelli MR, Rossi F, Filippelli A.
Self-prescribed laxative use: a drug-utilization review.
Adv Ther 2002 Sep-Oct;19:(5):203-8
https://www.advancesintherapy.com/frame.asp?https://www.advancesintherapy.com/detail.aspx?ID=272
HSL2088
Fugh-Berman A, Pearson C.
The overselling of hormone replacement therapy.
Pharmacotherapy 2002 Sep;22:(9):1205-8
HSL2136
Caamano F, Figueiras A , Gestal-Otero JJ.
Influence of commercial information on prescription quantity in primary care.
Eur J Public Health 2002 Sep;12:(3):187-91
http://eurpub.oxfordjournals.org/cgi/reprint/12/3/187?maxtoshow=&HITS=10&hits=10&RESULTFORMAT=&author1=Caamano%2C+F&andorexactfulltext=and&searchid=1124411285121_316&stored_search=&FIRSTINDEX=0&sortspec=relevance&resourcetype=1&journalcode=eurpub
HSL2476
Cox ER, Henderson RR.
Prescription use behavior among medicare beneficiaries with capped prescription benefits.
J Manag Care Pharm 2002 Sep-Oct;8:(5):360-4
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=14613402
HSL7658
De Las Cuevas C, Sanz EJ, De La Fuente JA.
Variations in antidepressant prescribing practice: clinical need or market influences?
Pharmacoepidemiol Drug Saf 2002 Sep;11:(6):515-22
HSL10629
Bachert C, El-Akkad T.
Patient preferences and sensory comparisons of three intranasal corticosteroids for the treatment of allergic rhinitis.
Ann Allergy Asthma Immunol 2002 Sep;89:(3):292-7
HSL12519
Le TV.
Money talks
Reportage 2002 Sep
http://www.reportage.uts.edu.au/stories/2002/media/pr2k9.html
HSL1807
Company News; Glaxo Seeks F.D.A. Approval Of Depression Treatment
2002 Aug 30
HSL2451
Health ACTION.
European Parliament soundly rejects move towards direct-to-consumer advertising. HAI Europe applauds Parliament's decision to protect public health, not industry's interests
2002 Aug 24;
http://www.haiweb.org/campaign/DTCA/pressreleaseEUrejectsDTCA.html
HSL2079
Sackett DL.
The arrogance of preventive medicine.
CMAJ 2002 Aug 20;167:(4):363-4
http://www.cmaj.ca/cgi/content/full/167/4/363
HSL2308
Sheldon T.
Dutch GPs call for ban on Novartis products.
BMJ 2002 Aug 17;325:(7360):355
http://bmj.bmjjournals.com/cgi/content/full/325/7360/355
HSL19860
Hansen J, Farrow N
Doctoring the Spin
Sunday 2002 Aug 16
http://sgp1.paddington.ninemsn.com.au/sunday/cover_stories/transcript_1121.asp
HSL1991
Philip Morris Muzzled Marketing of Cessation Products
Join Together 2002 Aug 15
http://www.jointogether.org/news/headlines/inthenews/2002/philip-morris-muzzled-of.html
HSL1929
Sweet M.
Australian media raises alarm over meningitis
BMJ 2002 Aug 14;325:604
http://bmj.com/cgi/content/full/325/7364/604
HSL1958
Shamasunder B, Bero L.
Financial ties and conflicts of interest between pharmaceutical and tobacco companies.
JAMA 2002 Aug 14;288:(6):738-44
http://jama.ama-assn.org/cgi/content/full/288/6/738
HSL2466
Fontanarosa PB, DeAngelis CD.
The importance of the journal embargo.
JAMA 2002 Aug 14;288:(6):748-50
http://jama.ama-assn.org/cgi/content/full/288/6/748
HSL1806
Petersen M.
Heartfelt Advice, Hefty Fees
New York Times 2002 Aug 11
http://www.nytimes.com/2002/08/11/business/heartfelt-advice-hefty-fees.html?pagewanted=1
HSL68
Gerstel J.
Who benefits when doctors endorse drugs?
The Tortonto Star 2002 Aug 9
HSL17392
Vogin GD
PhRMA Adopts New Marketing Code
Medscape Medical News 2002 Aug 9
http://www.medscape.com/viewarticle/439960
HSL17394
Vogin GD
PhRMA Code: A Newsmaker Interview with John T. Kelly, MD, PhD
Medscape Medical News 2002 Aug 9
HSL2253
Kjaergard LL, Als-Nielsen B.
Association between competing interests and authors' conclusions: epidemiological study of randomised clinical trials published in the BMJ.
BMJ 2002 Aug 3;325:(7358):249
http://bmj.com/cgi/content/full/325/7358/249
HSL17377
Society of General Internal Medicine
Policy on Acceptance and Disclosure of External Funds
Society of General Internal Medicine 2002 Aug 2
HSL1892
Molloy W, Strang D, Guyatt G, Lexchin J, Bedard M, Dubois S, Russo R.
Assessing the quality of drug detailing.
J Clin Epidemiol 2002 Aug;55:(8):825-32
HSL2505
[No authors listed].
Is Yasmin a 'truly different' drug?
Drug Ther Bull 2002 Aug;40:(8):57-9
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=12216337
HSL17376
Koerner BI
First, you market the disease... then you push the pills to treat it
The Guardian 2002 July 30
http://www.guardian.co.uk/news/2002/jul/30/medicineandhealth
HSL1775
Williams A.
The mental health industry
2002 Jul 16
HSL13260
Antonuccio DO, Burns DD, Danton WG.
Antidepressants: A triumph of marketing over science?
Prevention & Treatment. 2002 Jul 15;5:(1):Item 25
http://content.apa.org/journals/pre/5/1/25
HSL14781
Fuller Torrey E.
The Going Rate on Shrinks
The American Prospect 2002 Jul 14
http://www.prospect.org/cs/articles?article=the_going_rate_on_shrinks
HSL20557
Moynihan R
Under the microscope
The Australian Financial Review 2002 July 1280
http://www.accessmylibrary.com/coms2/summary_0286-25921057_ITM
HSL2481
CMAJ
The invisible hand of the marketing department.
CMAJ 2002 Jul 9;167:(1):5
http://www.cmaj.ca/cgi/content/full/167/1/5
HSL1772
Doctors under fire over drug company payments
2002 Jul 5
HSL1962
Rosack J.
Drug industry responds to complaints about marketing
Psychiatric News 2002 Jul 5;37:(13):1
http://pn.psychiatryonline.org/cgi/content/full/37/13/1
HSL2303
Lehner JP, Meyer F, Juillet Y.
[Communication and transparency concerning risk-benefit analysis in public health: the example of medication]
Therapie. 2001 Jul-Aug;56(4):335-9 2002 Jul-Aug 01;56:(4):335-9
HSL2503
Health plans keeping drug cost increases in check with programs that promote generics.
Capitation Manag Rep. 2002 July 01;9:(7):101-3
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=12164057
HSL5326
Doolan DF, Bates DW.
Computerized physician order entry systems in hospitals: mandates and incentives.
Health Aff (Millwood) 2002 Jul-Aug 01;21:(4):180-8
http://content.healthaffairs.org/cgi/reprint/21/4/180
HSL1925
Theroux R.
Bypassing the middleman: a grounded theory of women's self-care for vaginal symptoms.
Health Care Women Int 2002 Jul-Aug;23:(5):417-31
http://journalsonline.tandf.co.uk/app/home/contribution.asp?wasp=258b145abdcf4aa3aee66667fe129285&referrer=parent&backto=issue,2,10;journal,28,59;linkingpublicationresults,1:101823,1
HSL1967
Quinn RJ, O'Neill C.
Attitudes of general practitioners to their interactions with pharmaceutical companies: a qualitative study.
Ir Med J 2002 Jul-Aug;95:(7):199-202
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=12227525
HSL2250
Klein JE, Fleischman AR.
The private practicing physician-investigator: ethical implications of clinical research in the office setting.
Hastings Cent Rep 2002 Jul-Aug;32:(4):22-6
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=12362520
HSL2478
Coolidge MP.
Drug samples: friend or foe?
J Drugs Dermatol 2002 Jul;1:(1):49-52
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=12847754
HSL2497
Bennett J, Collins J.
The relationship between physicians and the biomedical industries: advice from the Royal College of Physicians.
Clin Med 2002 Jul-Aug;2:(4):320-2
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=12195858
HSL2452
Hoye S, Hjortdahl P.
New wonder pill!--what do Norwegian newspapers write
2002 Jun 30;122(17):1671-6 2002 June 30;122:(17):1671-6
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=12555610
HSL1692
Redelmeier DA, Cialdini RB.
Problems for clinical judgement: 5. Principles of influence in medical practice
CMAJ 2002 Jun 25;166:(13):1680-4
http://www.cmaj.ca/cgi/content/full/166/13/1680
HSL17901
Hunter M
UK consumers reject direct advertising to patients by drug industry
BMJ 2002 Jun 15;324:(7351):1416
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1172194/
HSL19049
Woloshin S, Schwartz LM, Welch HG.
Tobacco money: up in smoke?
Lancet 2002 June 15;359:(9323):2108-11
http://linkinghub.elsevier.com/retrieve/pii/S0140-6736(02)08939-0
HSL2245
Leenen FH.
Conflicts of interest and libel action.
N Engl J Med 2002 Jun 13;346:(24):1919-20
HSL2470
Drazen JM, Curfman GD.
Financial associations of authors.
N Engl J Med 2002 Jun 13;346:(24):1901-2
http://content.nejm.org/cgi/content/full/346/24/1901
HSL2473
Detsky A[AU].
Dr Detsky replies
NEJM 2002 Jun 13;346:(24):1920
HSL17902
Mayor S
Researchers claim clinical trials are reported with misleading statistics
BMJ 2002 Jun 8;324:(7350):1353
http://www.bmj.com/cgi/content/extract/324/7350/1353/a
HSL19051
Schwartz LM, Woloshin S, Baczek L.
Media coverage of scientific meetings: too much, too soon?
JAMA 2002 June 8;287:(21):2859-63
http://jama.ama-assn.org/content/287/21/2859.long
HSL1771
Hawkes N.
How to spot a 'misleading' health story
2002 Jun 5
HSL17903
Woloshin S, Schwartz LM.
Press releases: translating research into news.
JAMA 2002 Jun 5;287:(21):2856-8
http://jama.ama-assn.org/cgi/content/full/287/21/2856
HSL19810
Rochon PA, Bero LA, Bay AM, Gold JL, Dergal JM, Binns MA, Streiner DL, Gurwitz JH
Comparison of Review Articles Published in Peer-Reviewed and Throwaway Journals
JAMA 2002 Jun 5;287:(21):2853-2856
http://jama.ama-assn.org/content/287/21/2853.full
HSL153
Stevenson K.
Health Forum: Out of the game: A frustrated psychiatrist abandons her practice to get out from under 'evaluating and medicating'
Post Gazette (Pittsburgh) 2002 Jun 4
HSL17905
Redfearn S
Journal: Drug Sales Based on 'Seriously Biased' Data
The Washington Post 2002 Jun 4
http://www.washingtonpost.com/wp-dyn/articles/A54319-2002Jun3.html
HSL5403
Orlowski JP, Christensen JA.
The potentially coercive nature of some clinical research trial acronyms.
Chest 2002 Jun 01;121:(6):2023-8
http://www.chestjournal.org/cgi/content/full/121/6/2023
HSL17906
Moynihan R
Celebrity selling
BMJ 2002 Jun 1;324:(7349):1342
http://www.bmj.com/cgi/content/citation/324/7349/1342?HITS=10&hits=10&stored;_search=&author1=Moynihan%2C%2BR&maxtoshow;=&FIRSTINDEX=0&resourcetype=1,2,3,4,10&searchid=1023661467365_9984&RESULTFORMAT;=
HSL1963
Ripamonti C, Bianchi M.
The use of methadone for cancer pain.
Hematol Oncol Clin North Am 2002 Jun;16:(3):543-55
HSL1969
Pinkus RL.
From Lydia Pinkham to Bob Dole: what the changing face of direct-to-consumer drug advertising reveals about the professionalism of medicine.
Kennedy Inst Ethics J 2002 Jun;12:(2):141-58
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=12476915
HSL10434
Tackling antibiotic waste.
Prescrire Int 2002 Jun;11:(59):93
HSL10435
Missing data.
Prescrire Int 2002 Jun;11:(59):92
HSL15304
Denig P, Witteman CL, Schouten HW.
Scope and nature of prescribing decisions made by general practitioners.
Qual Saf Health Care 2002 Jun;11:(2):137-43
http://qshc.bmj.com/cgi/content/full/11/2/137
HSL1769
Vedantam S.
Industry Role in Medical Meeting Decried
Washington Post Staff Writer 2002 May 26
HSL2484
Charatan F.
Doctor sues company over unethical marketing.
BMJ 2002 May 25;324:(7348):1234
http://bmj.com/cgi/content/full/324/7348/1234/b
HSL17907
How Whistleblowing cost one doctor £550,000
BMJ 2002 May 25;
http://www.bmj.com/cgi/content/extract/324/7348/1240
HSL17913
Burton B
Australia turns to drug company representatives to cut prescribing
BMJ 2002 May 25;324:(7348):1234
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1123208/
HSL17914
Ed.
Europe on the brink of direct-to-consumer drug advertising
Lancet 2002 May 18;359:(9319):1709
http://www.lancet.com/journals/lancet/article/PIIS0140-6736(02)08637-3/fulltext
HSL1768
Petersen M.
Suit Says Company Promoted Drug in Exam Rooms
The New York Times 2002 May 15
http://www.ncbi.nlm.nih.gov/pubmed/12056438
HSL1767
Health Fact Sheet 1 – Securing the future of the Pharmaceutical Benefits Scheme
2002 May 14
HSL17912
Ferris LE.
Industry-sponsored pharmaceutical trials and research ethics boards: are they cloaked in too much secrecy?
CMAJ 2002 May 14;166:(10):1279-80
http://www.cmaj.ca/cgi/content/full/166/10/1279
HSL1838
Romano M.
Student rally Med school attendees write ethics code on drug firms.
Mod Healthc 2002 May 13;32:(19):24,
HSL17910
Spurgeon D
Doctors accept $50 a time to listen to drug representatives
BMJ 2002 May 11;324:(7346):1113
http://www.bmj.com/cgi/content/extract/324/7346/1113/a
HSL17393
Silverman E
Drug maker cancels tony N.Y. 'lecture'
The Star Ledger 2002 May 10
HSL17908
Gottlieb S
Drug companies maintain 'astounding' profits.
BMJ 2002 May 4;324:(7345):1054
http://www.bmj.com/cgi/content/extract/324/7345/1054/b
HSL17916
The Science of Persuasion
The Economist 2002 May 2
http://www.economist.com/displaystory.cfm?story_id=1109515
HSL3700
Lasser KE, Allen PD, Woolhandler SJ, Himmelstein DU, Wolfe SM, Bor DH.
Timing of new black box warnings and withdrawals for prescription medications.
JAMA 2002 May 1;287:(17):2215-20
http://jama.ama-assn.org/cgi/content/full/287/17/2215
Page 155 of 206 pages ‹ First < 153 154 155 156 157 > Last ›
